Inflammation and immunity in cancer
著者
書誌事項
Inflammation and immunity in cancer
Springer, c2015
大学図書館所蔵 全3件
  青森
  岩手
  宮城
  秋田
  山形
  福島
  茨城
  栃木
  群馬
  埼玉
  千葉
  東京
  神奈川
  新潟
  富山
  石川
  福井
  山梨
  長野
  岐阜
  静岡
  愛知
  三重
  滋賀
  京都
  大阪
  兵庫
  奈良
  和歌山
  鳥取
  島根
  岡山
  広島
  山口
  徳島
  香川
  愛媛
  高知
  福岡
  佐賀
  長崎
  熊本
  大分
  宮崎
  鹿児島
  沖縄
  韓国
  中国
  タイ
  イギリス
  ドイツ
  スイス
  フランス
  ベルギー
  オランダ
  スウェーデン
  ノルウェー
  アメリカ
注記
Other editors: Misako Matsumoto, Keiko Udaka, and Noriyuki Sato
Includes bibliographycal references and index
収録内容
- From the knowledge of immunity and inflammation to immunotherapy against cancer / Tsukasa Seya
- Role of bone Marrow-Derived CCR1[+] cells in colon cancer invasion and metastasis / Makoto Mark Taketo
- PGE[2]-associated inflammation and gastrointestinal tumorigenesis / Hiroko Oshima, Masanobu Oshima
- The role of innate immune signaling in regulation of tumor-associated myeloid cells / Hiroaki Shime, Misako Matsumoto, Tsukasa Seya
- The role of PIKfyve in toll-like receptor-mediated responses / Kaoru Hazeki, Kiyomi Nigorikawa, Osamu Hazeki
- Emerging roles of an innate immune regulator TAPE in the toll-like receptor and RIG-I-like receptor pathways / Kuan-Ru Chen, Pin Ling
- Anchorage-dependent multicellular aggregate formation induces CD44 high cancer stem cell-like phenotypes in adult T cell Leukemia/Lymphoma cells / Yukiko Miyatake, Masanori Kasahara
- Innate immune receptor signaling and IRF family of transcription factors / Hiroaki Ikushima, Hideyuki Yanai, Tadatsugu Taniguchi
- Host factors involved in the propagation and pathogenesis of hepatitis C virus / Toru Okamoto, Yoshiharu Matsuura
- Hepatitis C virus (HCV)-induced inflammation / Hironori Nishitsuji ...[et. al]
- Development of immunotherapy for hepatocellular carcinoma / Eishiro Mizukoshi, Shuichi Kaneko
- Development of Glypican-3-targeted cancer immunotherapy / Toshiaki Yoshikawa ...[et. al]
- The vesicular traffic system in plasmacytoid dendritic cells as a target for immune regulation / Norimitsu Kadowaki
- In vivo targeting of dendritic cells with artificial adjuvant vector cells (aAVC) as a novel cancer immunotherapy / Shin-ichiro Fujii ...[et. al]
- Enhancement of efficacy of wilms' tumor gene WT1 product-derived peptide cancer vaccine by co-administration with Immunopotentiating agents / Hiroko Nakajima ...[et. al]
- Regulation of antigen presentation by dendritic cells and its application to cancer immunotherapy / Hidemitsu Kitamura ...[et. al]
- A new mode of cytotoxic T lymphocyte induction secondary to alteration of the peptide/Major histocompatibility complex class I repertoire by antigen processing defects / Takayuki Kanaseki, Yosuke Shionoya, Noriyuki Sato
- Progress in clinical use of CC chemokine receptor 4 antibody for regulatory T cell suppression / Susumu Suzuki ...[et. al]
- Adjuvant immunotherapy for cancer / Misako Matsumoto, Masahiro Azuma, Tsukasa Seya
- Immunological regulation of human cancer stem Cells/Cancer-Initiating cells / Noriyuki Sato ...[et. al]
- Development of personalized combination cancer immunotherapy based on the patients' immune status / Yutaka Kawakami ...[et. al]